Literature DB >> 31702856

Discovery of a Cryptic Intermediate in Late Steps of Mithramycin Biosynthesis.

Ryan Wheeler1, Xia Yu1,2, Caixia Hou1, Prithiba Mitra1, Jhong-Min Chen1, Frank Herkules3, Dmitri N Ivanov3, Oleg V Tsodikov1, Jürgen Rohr1.   

Abstract

MtmOIV and MtmW catalyze the final two reactions in the mithramycin (MTM) biosynthetic pathway, the Baeyer-Villiger opening of the fourth ring of premithramycin B (PMB), creating the C3 pentyl side chain, strictly followed by reduction of the distal keto group on the new side chain. Unexpectedly this results in a C2 stereoisomer of mithramycin, iso-mithramycin (iso-MTM). Iso-MTM undergoes a non-enzymatic isomerization to MTM catalyzed by Mg2+ ions. Crystal structures of MtmW and its complexes with co-substrate NADPH and PEG, suggest a catalytic mechanism of MtmW. The structures also show that a tetrameric assembly of this enzyme strikingly resembles the ring-shaped β subunit of a vertebrate ion channel. We show that MtmW and MtmOIV form a complex in the presence of PMB and NADPH, presumably to hand over the unstable MtmOIV product to MtmW, yielding iso-MTM, as a potential self-resistance mechanism against MTM toxicity.
© 2020 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  biocatalysis; biosynthesis; isomerization; natural products; protein structures

Mesh:

Substances:

Year:  2019        PMID: 31702856      PMCID: PMC6940538          DOI: 10.1002/anie.201910241

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  29 in total

1.  Characterization of kinetics and products of the Baeyer-Villiger oxygenase MtmOIV, the key enzyme of the biosynthetic pathway toward the natural product anticancer drug mithramycin from Streptomyces argillaceus.

Authors:  Miranda Gibson; Mohammad Nur-e-alam; Fredilyn Lipata; Marcos A Oliveira; Jürgen Rohr
Journal:  J Am Chem Soc       Date:  2005-12-21       Impact factor: 15.419

2.  Antibiotic resistance is ancient.

Authors:  Vanessa M D'Costa; Christine E King; Lindsay Kalan; Mariya Morar; Wilson W L Sung; Carsten Schwarz; Duane Froese; Grant Zazula; Fabrice Calmels; Regis Debruyne; G Brian Golding; Hendrik N Poinar; Gerard D Wright
Journal:  Nature       Date:  2011-08-31       Impact factor: 49.962

3.  Identification of the novobiocin biosynthetic gene cluster of Streptomyces spheroides NCIB 11891.

Authors:  M Steffensky; A Mühlenweg; Z X Wang; S M Li; L Heide
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

4.  Mithramycin selectively inhibits transcription of G-C containing DNA.

Authors:  D M Miller; D A Polansky; S D Thomas; R Ray; V W Campbell; J Sanchez; C A Koller
Journal:  Am J Med Sci       Date:  1987-11       Impact factor: 2.378

5.  How mithramycin stereochemistry dictates its structure and DNA binding function.

Authors:  Caixia Hou; Jürgen Rohr; Sean Parkin; Oleg V Tsodikov
Journal:  Medchemcomm       Date:  2019-03-28       Impact factor: 3.597

6.  Identification of an inhibitor of the EWS-FLI1 oncogenic transcription factor by high-throughput screening.

Authors:  Patrick J Grohar; Girma M Woldemichael; Laurie B Griffin; Arnulfo Mendoza; Qing-Rong Chen; Choh Yeung; Duane G Currier; Sean Davis; Chand Khanna; Javed Khan; James B McMahon; Lee J Helman
Journal:  J Natl Cancer Inst       Date:  2011-06-08       Impact factor: 13.506

7.  Development of Mithramycin Analogues with Increased Selectivity toward ETS Transcription Factor Expressing Cancers.

Authors:  Prithiba Mitra; Joseph M Eckenrode; Abhisek Mandal; Amit K Jha; Shaimaa M Salem; Markos Leggas; Jürgen Rohr
Journal:  J Med Chem       Date:  2018-08-28       Impact factor: 7.446

8.  Mithramycin SK, a novel antitumor drug with improved therapeutic index, mithramycin SA, and demycarosyl-mithramycin SK: three new products generated in the mithramycin producer Streptomyces argillaceus through combinatorial biosynthesis.

Authors:  Lily L Remsing; Ana M González; Mohammad Nur-e-Alam; M José Fernández-Lozano; Alfredo F Braña; Uwe Rix; Marcos A Oliveira; Carmen Méndez; José A Salas; Jürgen Rohr
Journal:  J Am Chem Soc       Date:  2003-05-14       Impact factor: 15.419

9.  Solution structure of the mithramycin dimer-DNA complex.

Authors:  M Sastry; D J Patel
Journal:  Biochemistry       Date:  1993-07-06       Impact factor: 3.162

10.  Dimerization and DNA recognition rules of mithramycin and its analogues.

Authors:  Stevi Weidenbach; Caixia Hou; Jhong-Min Chen; Oleg V Tsodikov; Jürgen Rohr
Journal:  J Inorg Biochem       Date:  2015-12-18       Impact factor: 4.155

View more
  1 in total

1.  Structure-function characterization of an aldo-keto reductase involved in detoxification of the mycotoxin, deoxynivalenol.

Authors:  Nadine Abraham; Kurt L Schroeter; Yan Zhu; Jonathan Chan; Natasha Evans; Matthew S Kimber; Jason Carere; Ting Zhou; Stephen Y K Seah
Journal:  Sci Rep       Date:  2022-08-30       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.